Journal
/
/
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
DOI:

07:20 min

January 14, 2011

, , , ,

Chapters

  • 00:05Title
  • 00:55Introduction
  • 01:48Mouse Model of Breast Cancer
  • 02:14Isolation of Lymphocytes
  • 03:44Determine Fold Expansion of T Cells by Cell Counts and Flow Cytometry Analysis
  • 04:58Determine Tumor-Specificity of the ex vivo Expanded T Cells
  • 05:47Selective Expansion of Tumor-Reactive T Cells with Effector Anti-Tumor Function
  • 06:53Conclusion

Summary

Automatic Translation

An efficient protocol for the ex vivo expansion of tumor-reactive T cells from tumor-draining lymph nodes or other secondary lymphoid tissues of tumor-bearing hosts is described. This protocol selectively expands tumor-specific T cells for use in adoptive immunotherapy of breast cancer.

Related Videos

Read Article